Good Life Advisors’s Tenet Healthcare THC Stock Holding History

Good Life Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,636	Closed	-$215K	–	439
2023 Q2	$215K	Buy	+2,636	New	+$188K	0.02%	360

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Good Life Advisors's THC Position: Q3 2023 in Review

Good Life Advisors sold out of Tenet Healthcare (THC) in Q3 2023, closing a stake of 2,636 shares — an estimated $215K sold.

Good Life Advisors first reported a position in THC in Q2 2023 and held it in 1 quarter. The position peaked at $215K in Q2 2023. 407 funds tracked by Wall St. Rank hold THC as of Q3 2023.

Good Life Advisors reported no remaining Tenet Healthcare position as of Q3 2023 after selling out during the quarter.
Good Life Advisors sold 2,636 Tenet Healthcare shares in Q3 2023, an estimated $215K.
Good Life Advisors first reported a position in Tenet Healthcare in Q2 2023 and held it in 1 quarter.
Good Life Advisors's Tenet Healthcare position peaked at $215K in Q2 2023.
407 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2023.

Based on Good Life Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.